000			01586 a2200433 4500
005			20250514215920.0
264		0	_c20050314
008			200503s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aMaude, Shannon L
245	0	0	_aCdk inhibition in human cells compromises chk1 function and activates a DNA damage response. _h[electronic resource]
260			_bCancer research _cFeb 2005
300			_a780-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAtaxia Telangiectasia Mutated Proteins
650	0	4	_aCDC2 Protein Kinase _xantagonists & inhibitors
650	0	4	_aCDC2-CDC28 Kinases _xantagonists & inhibitors
650	0	4	_aCell Cycle Proteins _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aCheckpoint Kinase 1
650	0	4	_aCyclin-Dependent Kinase 2
650	0	4	_aCyclin-Dependent Kinases _xantagonists & inhibitors
650	0	4	_aDNA Damage _xphysiology
650	0	4	_aDNA-Binding Proteins _xmetabolism
650	0	4	_aDown-Regulation
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aHeLa Cells
650	0	4	_aHistones _xmetabolism
650	0	4	_aHumans
650	0	4	_aKinetin
650	0	4	_aProtein Kinases _xbiosynthesis
650	0	4	_aProtein Serine-Threonine Kinases _xmetabolism
650	0	4	_aPurines _xpharmacology
650	0	4	_aRoscovitine
650	0	4	_aTumor Suppressor Proteins _xmetabolism
700	1		_aEnders, Greg H
773	0		_tCancer research _gvol. 65 _gno. 3 _gp. 780-6
999			_c15382057 _d15382057